Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions
Authors:
- Verena KopfnagelVKVerena Kopfnagel
- Jürgen HarderJHJürgen Harder
- Thomas WerfelTWThomas Werfel
- 1 October 2013
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 13 (5) , 531-536
Abstract
To summarize the findings on the expression of antimicrobial peptides in the skin in inflammatory skin diseases and particularly in atopic dermatitis. Moreover, the literature addressing the functions of antimicrobial peptides (AMPs) beyond antimicrobial activities with impact on allergic skin inflammation is summarized as well. Although lower expressed than in psoriasis, most AMPs have been shown to be either constitutively expressed or upregulated in atopic dermatitis as well. A number of immunoregulatory functions which might impact on allergic skin inflammation have been described for several antimicrobial peptides, mainly for human β-defensins and the cathelicidin LL-37. From the recent literature, there is considerable evidence that AMPs are induced in the skin in atopic dermatitis. However, some studies suggest that the induction, release or mobilization of some AMPs in atopic dermatitis may not reach sufficient levels to provide adequate control of cutaneous microbial colonization. Th2 cytokines appear to negatively influence the expression and induction of some AMPs. A number of immunoregulatory functions have been described for several AMPs. Most of them point to a proinflammatory function of AMPs in addition to their antimicrobial activities. Further studies are needed to clarify the role of AMPs in atopic dermatitis.Keywords
This publication has 42 references indexed in Scilit:
- The skin surface as antimicrobial barrier: present concepts and future outlooksExperimental Dermatology, 2012
- Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human β-defensin-3Journal of Allergy and Clinical Immunology, 2008
- Mechanism of HBD-3 deficiency in atopic dermatitisClinical Immunology, 2006
- Cathelicidin deficiency predisposes to eczema herpeticumJournal of Allergy and Clinical Immunology, 2006
- Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic DermatitisJournal of Investigative Dermatology, 2005
- Deficiency of Dermcidin-Derived Antimicrobial Peptides in Sweat of Patients with Atopic Dermatitis Correlates with an Impaired Innate Defense of Human Skin In VivoThe Journal of Immunology, 2005
- Antimicrobial Peptides in Human Skin2005
- Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response GenesThe Journal of Immunology, 2003
- RNase 7, a Novel Innate Immune Defense Antimicrobial Protein of Healthy Human SkinJournal of Biological Chemistry, 2002
- Endogenous Antimicrobial Peptides and Skin Infections in Atopic DermatitisNew England Journal of Medicine, 2002